There is a lot of information that is yet to be published about cancer prevention and treatment. Providing a lot of awareness about cancer can be a great strategy to prevent the disease and help advance its treatment. We have seen a lot of research in recent years about oncoproteins, oncogenes, tumor suppressors, signal transduction, cellular response processes, intercellular interactions and dysfunction. Follow Oncotarget on Twitter.
Oncotarget promotes the publication of cancer as instrumental in the multidisciplinary field of oncology research. The new information about this disease should be translated from theory to clinical practice over time. The release of research papers can touch on various aspects of scientific inquiry such as molecular biology, physiology, pathology, pharmacology, oncology as well as other medical departments.
— Oncotarget (@OncotargetJrnl) December 12, 2017
Cancer is a significant disease that causes death and increases financial constraints on government hospitals. Although there are many strategies put in place to control the deadly disease, there is a need to incorporate oncotarget as one of these approaches. Oncotarget provides publications on general translational and clinical research with scientific analysis. It is better than articles that are based on mere opinions and perspectives of ordinary people. Oncotarget offers a broad scope of detailed study on the different therapies useful in treating breast cancer. It also provides other unique features that will transform the way publication of cancer research takes place in the long run.
The introduction of Oncotarget in the field of cancer treatment has made it easy for many stakeholders in different medical disciplines to access information. The Oncotarget journal has numerous therapies that can be used to combat the disease. The information provided for specific types of cancer can be vital for treating the disease. Listen to Oncotarget podcast on Player.FM.
Through Oncotarget, you can learn about medicines that are used to heal infections and other ailments that can also be used by cancer patients in the future. Such drug effects and side effects are known by clinicians and recommended for patients with cancer. Many of the drugs that treat other diseases can be relevant to managing the cancer-related disorders too. That’s why Oncotarget covers all molecules, cellular functions, pathways, cell types, tissues and treatments that may be relevant to cancer today.
Learn more: https://www.ncbi.nlm.nih.gov/pmc/journals/1558/